Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). DOP53 Clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active ulcerative colitis. Journal of Crohn's and colitis. pp. S060-S061. [Online].